Point mutations of CTNNB1 and AXIN1, likely activating the WNT pathway, also were restricted to invasive or metastatic stages (Supplementary Fig. 8) often contributing to genetically heterogeneous subclones within the primary tumor. This evidence concerns the gene CTNNB1 and neoplasm.